home All News open_in_new Full Article

Un medicament experimental reduce cu aproape 94% factorul de risc pentru boli cardiace

Un medicament experimental dezvoltat de compania farmaceutică Eli Lilly a dat rezultate impresionante într-un studiu clinic de fază intermediară. Acesta a redus semnificativ nivelurile unui factor de risc genetic pentru bolile cardiovasculare.


today 4 d. ago attach_file Science

attach_file Science
attach_file Science
attach_file Economics
attach_file Science
attach_file Politics
attach_file Events
attach_file Politics
attach_file Science
attach_file Science
attach_file Science
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Science
attach_file Science
attach_file Economics
attach_file Science


ID: 2565840204
Add Watch Country

arrow_drop_down